ESI vs RARE · P/E 64, rev $2.55B vs rev $350.0M
Element Solutions Inc (ESI) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Element Solutions Inc (ESI) is a specialty chemicals company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported ESI revenue for 2025-12-31 was $2.55B. Net income was $190.8M. Revenue was up 3.8% from 2024-12-31 to 2025-12-31. ESI currently screens at market cap $9.71B and trailing P/E 64.3.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
ESI currently screens at market cap $9.71B and trailing P/E 64.3. RARE currently screens at market cap $2.79B.
Not investment advice. Open the ESI and RARE stock pages for the full models.
Not investment advice.